Polypharmacology of ambroxol in the treatment of COVID-19

The pandemic of coronavirus disease 2019 (COVID-19) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still underway. Due to the growing development of severe symptoms, it is necessary to promote effective therapies. Ambroxol [2-amino-3,5-dibromo-N-(trans-4-hydroxycyclohexyl) benzyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ziyuan, Yang, Minghui, Chen, Xi, Xiao, Rongxin, Dong, Yu, Chu, Ming, Song, Guojie, Wang, Yuedan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2023
Materias:
Chemical Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970826/
https://www.ncbi.nlm.nih.gov/pubmed/36651548
http://dx.doi.org/10.1042/BSR20221927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970826/
https://www.ncbi.nlm.nih.gov/pubmed/36651548
http://dx.doi.org/10.1042/BSR20221927

Ejemplares similares